Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP620756.RAsnhwMXpkMiaD-F3YBqUcbpp3tCmn0AUVNfE5zQxXbHs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP620756.RAsnhwMXpkMiaD-F3YBqUcbpp3tCmn0AUVNfE5zQxXbHs130_assertion type Assertion NP620756.RAsnhwMXpkMiaD-F3YBqUcbpp3tCmn0AUVNfE5zQxXbHs130_head.
- NP620756.RAsnhwMXpkMiaD-F3YBqUcbpp3tCmn0AUVNfE5zQxXbHs130_assertion description "[PIK3CA mutations are present in approximately 40% of luminal BCs but are not an independent predictor of outcome in the context of endocrine therapy, whereas RAS/RAF mutations are rare inluminal BC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620756.RAsnhwMXpkMiaD-F3YBqUcbpp3tCmn0AUVNfE5zQxXbHs130_provenance.
- NP620756.RAsnhwMXpkMiaD-F3YBqUcbpp3tCmn0AUVNfE5zQxXbHs130_assertion evidence source_evidence_literature NP620756.RAsnhwMXpkMiaD-F3YBqUcbpp3tCmn0AUVNfE5zQxXbHs130_provenance.
- NP620756.RAsnhwMXpkMiaD-F3YBqUcbpp3tCmn0AUVNfE5zQxXbHs130_assertion SIO_000772 25071141 NP620756.RAsnhwMXpkMiaD-F3YBqUcbpp3tCmn0AUVNfE5zQxXbHs130_provenance.
- NP620756.RAsnhwMXpkMiaD-F3YBqUcbpp3tCmn0AUVNfE5zQxXbHs130_assertion wasDerivedFrom befree-20150227 NP620756.RAsnhwMXpkMiaD-F3YBqUcbpp3tCmn0AUVNfE5zQxXbHs130_provenance.
- NP620756.RAsnhwMXpkMiaD-F3YBqUcbpp3tCmn0AUVNfE5zQxXbHs130_assertion wasGeneratedBy ECO_0000203 NP620756.RAsnhwMXpkMiaD-F3YBqUcbpp3tCmn0AUVNfE5zQxXbHs130_provenance.